MSH|^~\&|IGENE|MFT|EPIC|MFT|20251014155942||ORU^R01|ORIE-251014-9|T|2.3PID||9737383397|B6789012^^^R0A^MR||TAMESIDE^Hodor||19600727|M|||^^^^OL7 0NSORC|RE|LRI-5280001675|||||||||||||||||||^^^^^R0A^^^ODSOBR|1|Acme23469|Gen825750|R377.1^Intellectual disability – microarray only^England-GenomicTestDirectory|R|201608030830|201608091650| Variables that Apply to Overall Study: Report Section 1OBX|1|TX|53577-3^Reason for study^LN|1|Patient has encephalopathy|OBX|2|CWE|51967-8^Genetic disease(s) assessed^LN|1|R377^Intellectual disability – microarray only^GenomicClinicalIndication|OBX|3|TX|81293-3^Description of ranges of DNA sequences examined^LN|1|Whole genome coverage, including subtelomeric and pericentromeric regions. Affymetrix Cytogenetics platform contains >2.1 million copy-number markers, including 750,000 single- nucleotide polymorphism (SNP) probes to detect copy number changes and LCSH.|OBX|4|CWE|83006-7^Deletion-duplication overall interpretation^LN|1| LA26804-7^Deletion and/or duplication detected in studied region^LN|OBX|5|FT|51969-4^Full narrative report^LN|1|Genetic Results: The cytogenomic microarray analysis indicated that there was a gain involving chromosome 16 (1.7 Mb duplicated) within 16p13.11, suggesting partial trisomy for this region. This duplication has been reported as a risk factor for neurocognitive disorders as it appears to be enriched in children with intellectual disabilities, but is also observed, at a lower frequency, in normal individuals. \.br\\.br\ Method: CHROMOSOMAL MICROARRAY ANALYSIS (CMA). \.br\\.br\ Methodology: This CMA was performed using Affymetrix(R) Cytogenetics Whole-Genome 2.7M Array. The array offers a total of 2,141,868 markers across the entire genome, including 1,742,975 unique non-polymorphic markers, and 398,891 SNP markers.|OBX|6|ST|81291-7^Structural variant ISCN^LN|1|arr16p13.11(14,686,844x2,14776269-16486370x3,16,494,405x2)(hg18)^ISCN|OBX|7|CWE|62374-4^Human reference sequence assembly^LN|1|LA26805-4^NCBI36^LN|OBX|8|CNE|83005-9^Variant Category^LN|2a|LA26802-1^StructuralVariant^LN|OBX|9|CWE|48019-4^DNA change type^LN|2a|LA6686-5^Duplication^LN|OBX|10|CWE|48001-2^Cytogenetic chromosome location^LN|2a|16p13.11^16p13.11^Chrom-Loc|OBX|11|CWE|81304-8^Variant analysis method type^LN|2a|LA26399-8^Oligo aCGH^LN|OBX|12|ST|82155-3^Copy number^LN|2a|3|